
Eflucimibe
CAS No. 202340-45-2
Eflucimibe( —— )
Catalog No. M34231 CAS No. 202340-45-2
Eflucimibe (L0081) is an acyl coenzyme A: cholesterol acyltransferase inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, and can be used to study atherosclerosis and hyperlipidemia.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 296 | Get Quote |
![]() ![]() |
5MG | 409 | Get Quote |
![]() ![]() |
10MG | 604 | Get Quote |
![]() ![]() |
25MG | 908 | Get Quote |
![]() ![]() |
50MG | 1251 | Get Quote |
![]() ![]() |
100MG | 1647 | Get Quote |
![]() ![]() |
500MG | 3312 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameEflucimibe
-
NoteResearch use only, not for human use.
-
Brief DescriptionEflucimibe (L0081) is an acyl coenzyme A: cholesterol acyltransferase inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, and can be used to study atherosclerosis and hyperlipidemia.
-
DescriptionEflucimibe (F 12511) is a new acyl-coenzyme A cholesterol O-acyltransferase (ACAT) inhibitor. Eflucimibe can be used in the research of atherosclerosis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorAcyltransferase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number202340-45-2
-
Formula Weight469.72
-
Molecular FormulaC29H43NO2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[C@H](C(NC1=C(C)C(C)=C(O)C(C)=C1)=O)(SCCCCCCCCCCCC)C2=CC=CC=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Nathalie Mesplet, et al. Analysis of eflucimibe and related impurities by highly sensitive liquid chromatography-electrospray-tandem mass spectrometry. The Journal of Separation Science. 2003.
molnova catalog



related products
-
Gymnemagenin
Gymnemagenin is a potent and selective antagonist for the β isoform of LXR it has antihyperglycemic activity.
-
MOG (35-55)
MOG (35-55) is a truncated peptide derived from the human Myelin Oligodendrocyte Glycoprotein (MOG).?
-
Pomalidomide-C2-NH2
Pomalidomide-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate containing a Pomalidomide-based cereblon ligand and a linker.